Business
Fangzhou Inc. Reports Strong Growth in 2024 Annual Results: 11.2% Revenue Growth and 139% Year-on-Year Increase in Adjusted Net Profit Driven by AI-Powered Innovation
Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced on March 21st, 2025 its financial results for fiscal year 2024, reporting total revenue of RMB 2.7 billion, representing an 11.2% year-over-year increase. Notably, the company's adjusted net profit reached RMB 17.2 million, a significant 139% growth compared to 2023, driven by ongoing technology enhancements and improvements in operating efficiency.
About this update from Fangzhou Inc.
[{"type":"text","content":"HONG KONG, March 23, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced on March 21st, 2025 its financial results for fiscal year 2024, reporting total revenue of RMB 2.7 billion, representing an 11.2% year-over-year increase. Notably, the company's adjusted net profit reached RMB 17.2 million, a significant 139% growth compared to 2023, driven by ongoing technology enhancements and improvements in operating efficiency.","length":526,"tagName":"p"},{"type":"image","alt":"Fangzhou Inc. (PRNewsfoto/Fangzhou Inc.)","displaySize":"","headline":null,"caption":"Fangzhou Inc. (PRNewsfoto/Fangzhou Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":127,"url":"https://media.zenfs.com/en/prnewswire.com/ec3b6ecc368092a3d079d531670f2342"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UzhMEweRObfFg12_yi_6IQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIyNDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/ec3b6ecc368092a3d079d531670f2342","width":400,"height":127}},"href":"https://mma.prnewswire.com/media/2544392/Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Dr. Xie Fangmin, founder, Chairman and CEO of Fangzhou Jianke, stated, "2024 marks another leap forward in the advancement of our H2H model, and the mission of bringing smart CDM services to our users. By aligning with national policies and harnessing the power of AI, we aim to build a dynamic, patient-centered ecosystem that propels the high-quality development of China's Internet healthcare sector."","length":423,"tagName":"p"},{"type":"text","content":"Serving Customers and Patients Through AI-Powered Innovation","length":60,"tagName":"p"},{"type":"text","content":"Guided by its mission of "AI Powered, Innovation-Driven Growth," the Company believes that technological innovation remains critical its growth and development. In 2024, the Company's research and development efforts in AI technologies, including large language models, big data, and cloud computing significantly increased the efficiency of chronic disease management across its platform. These innovations also fueled robust user growth, with registered users on the Jianke Platform reaching 49.2 million as of December 31, 2024...